You are here

  • Home
  • Archive
  • Volume 28, Issue Suppl 1
  • 5PSQ-198 Variations in effectiveness and safety of glecaprevir/pibrentasvir among hepatitis C patients with different genotypes: a multi-institutional cohort study in Taiwan

Article metrics

Article menu

Download PDFPDF

Section 5: Patient safety and quality assurance
5PSQ-198 Variations in effectiveness and safety of glecaprevir/pibrentasvir among hepatitis C patients with different genotypes: a multi-institutional cohort study in Taiwan

 

Online download statistics by month:

Online download statistics by month: March 2021 to November 2024

AbstractFullPdf
Mar 202126010
Apr 20214305
May 2021207
Jun 2021204
Jul 2021102
Aug 2021102
Sep 2021103
Oct 202112021
Nov 202110014
Dec 20212005
Jan 2022901
Feb 20221602
Mar 2022001
Apr 20221503
May 2022708
Jun 2022504
Jul 2022501
Aug 2022201
Sep 20222006
Oct 2022704
Nov 2022703
Dec 20221401
Jan 20231404
Feb 20231801
Mar 2023401
Apr 2023200
Jun 2023200
Jul 2023403
Aug 20231401
Sep 2023502
Nov 20231101
Dec 20231302
Jan 20242001
Feb 2024600
Mar 2024407
Apr 20241000
May 20241203
Jun 20242001
Jul 2024202
Aug 2024802
Sep 20241504
Oct 2024900
Nov 2024702
Total4250145